Group 1 - SiriusPoint (SPNT) closed at $18.72, with a 1.8% gain over the past four weeks, and a mean price target of $25 indicates a 33.6% upside potential [1] - The average price targets range from a low of $20.00 to a high of $30.00, with a standard deviation of $5, suggesting a variability in estimates [2] - Analysts show a strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 5.6% over the past month, with two estimates going higher and no negative revisions [12] - SPNT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Group 1 - ARKO Corp. shares have increased by 25.3% over the past four weeks, closing at $5, with a mean price target of $6.63 indicating a potential upside of 32.6% [1] - The mean estimate consists of four short-term price targets with a standard deviation of $2.21, where the lowest estimate is $4.50 (10% decline) and the highest is $9.00 (80% increase) [2] - Analysts show strong agreement on ARKO's ability to report better earnings, with a positive trend in earnings estimate revisions suggesting potential upside [4][11] Group 2 - The Zacks Consensus Estimate for ARKO's current year earnings has increased by 112.5% over the last 30 days, with no negative revisions [12] - ARKO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can indicate the direction of price movement [14]

Group 1: Stock Performance and Price Targets - Deluxe (DLX) closed at $19.66, with a 26.1% gain over the past four weeks, and a mean price target of $26.75 suggests a 36.1% upside potential [1] - The mean estimate includes four short-term price targets with a standard deviation of $2.75, indicating variability; the lowest estimate is $24.00 (22.1% increase), while the highest is $30.00 (52.6% increase) [2] - A tight clustering of price targets, represented by a low standard deviation, indicates high agreement among analysts about the stock's price movement direction [9] Group 2: Analyst Insights and Earnings Estimates - Analysts have shown increasing optimism about DLX's earnings prospects, with strong agreement in revising EPS estimates higher, which correlates with potential stock upside [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.2%, with one estimate moving higher and no negative revisions [12] - DLX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential upside [13] Group 3: Caution on Price Targets - While price targets are sought after by investors, they can often mislead; empirical research shows that they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should treat price targets with skepticism and not rely solely on them for investment decisions [10]

Group 1 - TTM Technologies (TTMI) shares have increased by 2.8% over the past four weeks, closing at $44.57, with a mean price target of $56.75 indicating a potential upside of 27.3% [1] - The mean estimate includes four short-term price targets with a standard deviation of $2.22, suggesting a consensus among analysts, with the lowest estimate at $55.00 (23.4% increase) and the highest at $60.00 (34.6% increase) [2] - Analysts show increasing optimism regarding TTMI's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for TTMI has increased by 0.2% due to one upward revision in earnings estimates over the last 30 days, with no negative revisions [12] - TTMI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While the consensus price target may not be a reliable indicator of the extent of TTMI's gains, it does provide a directional guide for potential price movement [14]

Core Viewpoint - Hillman Solutions Corp. (HLMN) has seen a 27.5% increase in share price over the past four weeks, closing at $9.88, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $12.5, representing a 26.5% upside [1]. Price Targets - The average price target consists of eight short-term estimates ranging from a low of $10.00 to a high of $15.00, with a standard deviation of $1.77, indicating variability among analysts [2]. - The lowest estimate suggests a 1.2% increase from the current price, while the highest estimate indicates a potential upside of 51.8% [2]. Analyst Sentiment - Analysts show a consensus that HLMN will report better earnings than previously estimated, which strengthens the outlook for the stock [4]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 3.1%, with two estimates moving higher and no negative revisions [12]. Zacks Rank - HLMN currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [13]. Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to concerns about analysts' biases and the accuracy of their estimates [3][7][10]. - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9].

Group 1 - The Pennant Group, Inc. (PNTG) shares have increased by 8.8% over the past four weeks, closing at $24.01, with a mean price target of $33.6 indicating a potential upside of 39.9% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $5.13, where the lowest estimate is $28.00 (16.6% increase) and the highest is $40.00 (66.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 3.3% over the past month [11][12] Group 2 - PNTG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While consensus price targets are often viewed as important, they should be approached with skepticism as they may not reliably indicate actual stock price movements [10][14] - Analysts' price targets can be influenced by business relationships, leading to potentially inflated estimates, but a low standard deviation among targets suggests a consensus on price direction [8][9]

Group 1 - VAREX IMAGING (VREX) shares have increased by 53.7% in the past four weeks, closing at $11.45, with a mean price target of $16.75 indicating a potential upside of 46.3% [1] - The average price targets range from a low of $10.00 to a high of $23.00, with a standard deviation of $5.38, suggesting variability in analyst estimates [2] - Analysts have shown strong agreement in revising earnings estimates higher, with a 59.5% increase in the Zacks Consensus Estimate for the current year, indicating positive earnings prospects [11][12] Group 2 - VREX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets can be misleading, the direction implied by the consensus price target appears to be a useful guide for potential price movement [14]

Core Viewpoint - Payoneer Global Inc. (PAYO) shows potential for significant upside, with a mean price target of $9.56 indicating a 41.4% increase from its current price of $6.76 [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $1.67, suggesting variability in analyst predictions [2] - The lowest estimate is $7.00, indicating a 3.6% increase, while the highest estimate is $12.00, suggesting a 77.5% increase [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Consensus - Analysts are optimistic about PAYO's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the last 30 days, three earnings estimates have been revised upward, leading to a 6% increase in the Zacks Consensus Estimate [12] - PAYO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, and reliance solely on them may not yield favorable returns [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Enliven Therapeutics, Inc. (ELVN) shows significant upside potential with a mean price target of $41.13, indicating a 102.4% increase from its current trading price of $20.32 [1][2]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $6.66, suggesting variability in analyst predictions. The lowest estimate is $33.00 (62.4% increase), while the highest is $52.00 (155.9% increase) [2]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding ELVN's earnings prospects, as evidenced by a positive trend in earnings estimate revisions. The Zacks Consensus Estimate for the current year has increased by 5.3% over the last 30 days, with two estimates moving higher and no negative revisions [11][12]. - ELVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]. Caution on Price Targets - While price targets are often sought after by investors, they can be misleading. Empirical research suggests that price targets rarely indicate actual stock price movements, and analysts may set overly optimistic targets due to business incentives [7][8][10].

Core Viewpoint - Avadel (AVDL) shares have increased by 39.7% in the past four weeks, closing at $14.85, with a mean price target of $19 indicating a potential upside of 28% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $2.88, where the lowest estimate is $16.00 (7.7% increase) and the highest is $24.00 (61.6% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising AVDL's earnings estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, four earnings estimates have been revised upward, leading to a 39.4% increase in the Zacks Consensus Estimate [12] Zacks Rank and Investment Potential - AVDL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting gains, they can indicate the direction of price movement [14]